Shares of pharmaceutical firm Cipla today surged nearly 9 per cent in morning trade as the company launched its generic drug used for treatment of asthma and chronic obstructive pulmonary disease in Germany and Sweden.
Tuesday, 2 September 2014
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment